CRO概念股表现强势 昭衍新药(06127.HK)涨11.52%
Mei Ri Jing Ji Xin Wen·2026-01-05 03:40

Group 1 - The CRO (Contract Research Organization) sector stocks are showing strong performance, with notable increases in share prices [1] - Zhaoyan New Drug (06127.HK) has risen by 11.52%, reaching HKD 22.26 [1] - Tigermed (03347.HK) has increased by 5.98%, now priced at HKD 44.98 [1] - WuXi AppTec (02359.HK) has gained 4.65%, with shares at HKD 105.7 [1] - Kanglong Chemical (03759.HK) has seen a rise of 4.59%, trading at HKD 20.74 [1]